A recent report published by Infinium Global Research on allergy immunotherapy market provides in-depth analysis of segments and sub-segments in the global as well as regional allergy immunotherapy market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional allergy immunotherapy market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global allergy immunotherapy market. According to the report, the global allergy immunotherapy market is projected to grow at a CAGR of 10.5% over the forecast period of 2019-2025.
AIT (Allergy Immunotherapy), is referred to as desensitization, it is the only treatment therapy that targets the cause of allergy. According to the WAO (World Allergy Organization), around 10%-40% of the total population of the world in 2013 is suffering from various allergy. AIT is a treatment option for asthma and environmental allergies. It is an ultimate goal to influence the immune system and its natural regulation through complex mechanisms.
The global allergy immunotherapy market is primarily driven by the rising consciousness of the patient's concern to the allergy treatment. Moreover, the development of novel products and the growing number of allergic patients is expected to fuel market growth in the near future. However, the allergy tablets are able to heal only a particular type of allergen and remain inefficient to avert the progress of asthma and new allergies are expected to hinder the demand for the global allergy immunotherapy market. Nonetheless, increasing awareness among Patients for allergies is anticipated to create a new opportunity for the global allergy immunotherapy market.
On the basis of region, the global allergy immunotherapy market is bifurcated into North America, Asia Pacific, Europe, Latin America, and the Middle East and Africa. Europe has held the largest revenue share of the global allergy immunotherapy market in 2018 and it is expected to be the dominating region in the coming years. Owing to rising in funding for research and development, high awareness, and grants, complimentary medical reimbursement policies. Europe is a highly influensive market for allergy immunotherapy and is estimated to grow at a significant growth rate within the projected years. Promising products of the clinical pipeline, and increasing allergic population. North America accounted for the second-largest market share for the global allergy immunotherapy market in 2018.
The report on global allergy immunotherapy market covers segments such as type, allergy type, and distribution channel. On the basis of type, the sub-markets include SLIT, and SCIT. On the basis of allergy type, the sub-markets include asthma, venom allergy, allergic rhinitis, food allergy, and others allergy type. On the basis of distribution channel, the sub-markets include retail pharmacy and drug stores, hospital pharmacy, and online pharmacy.
The report provides profiles of the companies in the market such as Aimmune Therapeutics, Biomay, Stallergenes Greer, Abello, Allergy Therapeutics, Merck, Circassia, HAL Allergy, Anergis, and DBV Technologies.
The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of allergy immunotherapy market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.
Get free analyst support for the queries before and post purchasing report.
Be assured of 100% customer satisfaction about the research and get 24X7 customer support.
Infinium has achieved over 400%+ growth in its repository and revenue over the last 2 years. Yes, we are proud to say we are growing at a great pace and becoming a trusted partner among our clients.
sign up for our newsletter
Infinium Global Research © 2019 All Rights Reserved